Aging of Natural Killer Cells in Acute Myeloid Leukemia

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Geriatric Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-319-44870-1_75-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute myeloid leukemia in the elderly (age 70 yr or older): long‐term survivors

  2017cited by this paper
• Immunosenescence: limitations of natural killer cell-based cancer immunotherapy

  2017cited by this paper
• Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches

  2016cited by this paper
• Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

  2016cited by this paper
• Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility

  2016cited by this paper
• Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy

  2016cited by this paper
• Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy.

  2016cited by this paper
• NK cells and type 1 innate lymphoid cells: partners in host defense

  2016cited by this paper
• Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?

  2016cited by this paper
• Exploitation of natural killer cells for the treatment of acute leukemia.

  2016cited by this paper
• Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients

  2016cited by this paper
• IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

  2016cited by this paper
• Editorial: NK Cell-Based Cancer Immunotherapy

  2016cited by this paper
• NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation

  2016cited by this paper
• Natural Killer Cells for Therapy of Leukemia

  2016cited by this paper
• Survival in acute myeloid leukemia is associated with NKp44 splice variants

  2016cited by this paper
• ‘Acute myeloid leukemia: a comprehensive review and 2016 update'

  2016cited by this paper
• Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells

  2015cited by this paper
• NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation

  2015cited by this paper
• Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy

  2015cited by this paper
• Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.

  2015cited by this paper
• Cytomegalovirus infection enhances the immune response to influenza

  2015cited by this paper
• NKG2D Receptor and Its Ligands in Host Defense

  2015cited by this paper
• Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age

  2015cited by this paper
• NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors

  2015cited by this paper
• Natural cytotoxicity receptor splice variants orchestrate the distinct functions of human natural killer cell subtypes

  2015cited by this paper
• The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer

  2015cited by this paper
• Balancing natural killer cell activation through paired receptors

  2015cited by this paper
• Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

  2015cited by this paper
• Natural killer cell mediated immunosurveillance of pediatric neuroblastoma

  2015cited by this paper
• The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

  2015cited by this paper
• Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

  2015cited by this paper
• A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.

  2015cited by this paper
• Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

  2014cited by this paper
• Effect of age and CMV on NK cell subpopulations.

  2014cited by this paper
• DNAM‐1 control of natural killer cells functions through nectin and nectin‐like proteins

  2014cited by this paper
• Orchestrating immune check-point blockade for cancer immunotherapy in combinations.

  2014cited by this paper
• Acute myeloid leukemia and myelodysplastic syndromes in older adults.

  2014cited by this paper
• LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses.

  2014cited by this paper
• Shaping of NK cell subsets by aging.

  2014cited by this paper
• Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications

  2014cited by this paper
• Age and cancer risk: a potentially modifiable relationship.

  2014cited by this paper
• The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.

  2014cited by this paper
• The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions

  2014cited by this paper
• Proinflammatory status influences NK cells subsets in the elderly.

  2014cited by this paper
• Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade

  2014cited by this paper
• CMV Latent Infection Improves CD8+ T Response to SEB Due to Expansion of Polyfunctional CD57+ Cells in Young Individuals

  2014cited by this paper
• Immunology of aging and cancer development.

  2013cited by this paper
• Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients

  2013cited by this paper
• Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells

  2013cited by this paper
• NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.

  2012cited by this paper
• Tumor‐induced changes in the phenotype of blood‐derived and tumor‐associated T cells of early stage breast cancer patients

  2012cited by this paper
• Decreased expression of DNAM‐1 on NK cells from acute myeloid leukemia patients

  2012cited by this paper
• Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.

  2012cited by this paper
• The impact of CMV infection on survival in older humans.

  2012cited by this paper
• Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

  2012cited by this paper
• Structure/function of human killer cell immunoglobulin‐like receptors: lessons from polymorphisms, evolution, crystal structures and mutations

  2011cited by this paper
• NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions

  2011cited by this paper
• Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands

  2011cited by this paper
• Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

  2011cited by this paper
• Immunosenescence of Human Natural Killer Cells

  2011cited by this paper
• Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.

  2011cited by this paper
• Increased killer immunoglobulin‐like receptor expression and functional defects in natural killer cells in lung cancer

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice

  2011cited by this paper
• Human NK Cells Proliferate and Die In Vivo More Rapidly than T Cells in Healthy Young and Elderly Adults

  2011cited by this paper
• The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.

  2010cited by this paper
• Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B

  2009cited by this paper
• Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

  2009cited by this paper
• The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

  2009cited by this paper
• The story of human cytomegalovirus and cancer: increasing evidence and open questions.

  2009cited by this paper
• CD96 Interaction with CD155 via Its First Ig-like Domain Is Modulated by Alternative Splicing or Mutations in Distal Ig-like Domains*

  2009cited by this paper
• Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-α and Ribavirin Treatment1

  2009cited by this paper
• Immunity, ageing and cancer

  2008cited by this paper
• NK cells and cancer immunosurveillance

  2008cited by this paper
• Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

  2007cited by this paper
• A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells.

  2007cited by this paper
• Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.

  2007cited by this paper
• Age and acute myeloid leukemia.

  2006cited by this paper
• The CD94/NKG2 family of receptors

  2006cited by this paper
• Variation of the Killer Cell Immunoglobulin-Like Receptors and HLA-C Genes in Nasopharyngeal Carcinoma

  2005cited by this paper
• Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

  2005cited by this paper
• Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

  2005cited by this paper
• Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

  2005cited by this paper
• Reciprocal age related change in natural killer cell receptors for MHC class I.

  2005cited by this paper
• Cutting Edge: CD96 (Tactile) Promotes NK Cell-Target Cell Adhesion by Interacting with the Poliovirus Receptor (CD155)

  2004cited by this paper
• Selective Depletion of CD56dim NK Cell Subsets and Maintenance of CD56bright NK Cells in Treatment-Naive HIV-1-Seropositive Individuals

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

  2001cited by this paper
• NK and NK/T cells in human senescence.

  2000cited by this paper
• Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper
• CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.

  1998cited by this paper
• LAG-3, a novel lymphocyte activation gene closely related to CD4

  1990cited by this paper

• CD 11b and CD56 As Prognostic Markers in Acute Myeloid Leukemia

  2024influential citation